Kadmon

YTD

ALL

Why Robinhood?

You can watch Kadmon and buy or sell other stocks, ETFs, and their options commission-free!

About KDMN

Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

CEO

Gustavo J. Pesquin, MBA

CEOGustavo J. Pesquin, MBA

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2010

Founded2010

Employees

—

Employees—

KDMN Key Statistics

Market cap

581.01M

Market cap581.01M

Price-Earnings ratio

-3.63

Price-Earnings ratio-3.63

Dividend yield

—

Dividend yield—

Average volume

1.98M

Average volume1.98M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$5.50

52 Week high$5.50

52 Week low

$2.30

52 Week low$2.30

People also own

Based on the portfolios of people who own KDMN. This list is generated using Robinhood data, and it’s not a recommendation.